open access publication

Article, 2024

Utility of ultrasound in the diagnostic work-up of suspected pulmonary embolism: an open-label multicentre randomized controlled trial (the PRIME study)

The Lancet Regional Health - Europe, ISSN 2666-7762, Volume 42, Page 100941, 10.1016/j.lanepe.2024.100941

Contributors

Falster, Casper 0000-0002-0389-5386 (Corresponding author) [1] [2] Mørkenborg, Mads Damgaard [3] Thrane, Mikkel Dreier 0000-0003-0724-3593 [1] Clausen, Jesper [4] Arvig, Michael Dan 0000-0001-5853-1953 [2] [5] [6] Brockhattingen, Kristoffer Kittelmann 0000-0002-3621-5463 [1] [2] Biesenbach, Peter [7] Paludan, Lasse [8] Nielsen, Rune Wiig [1] [2] Huynh, Thi Anh Nhi [3] Poulsen, Mikael Kjaer K 0000-0003-4051-7197 [1] Brabrand, Mikkel 0000-0002-3340-8251 [1] Møller, Jacob Eifer 0000-0003-2873-5845 [1] Posth, Stefan 0000-0002-4325-038X [1] Laursen, Christian Borbjerg 0000-0001-6382-9906 [1] [2]

Affiliations

  1. [1] Odense University Hospital
  2. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  3. [2] University of Southern Denmark
  4. [NORA names: SDU University of Southern Denmark; University; Denmark; Europe, EU; Nordic; OECD];
  5. [3] Department of Emergency Medicine, Gødstrup Hospital, Herning, Denmark
  6. [NORA names: Denmark; Europe, EU; Nordic; OECD];
  7. [4] Svendborg Sygehus
  8. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  9. [5] Næstved, Slagelse and Ringsted Hospitals
  10. [NORA names: Region Zealand; Hospital; Denmark; Europe, EU; Nordic; OECD];

Abstract

Background Prevalence of pulmonary embolism (PE) in patients referred to diagnostic imaging is decreasing, indicating a need for improving patient selection. The aim of this study was to assess reduction in referral to diagnostic imaging by integrating a bespoke ultrasound protocol and describe associated failure rate and adverse events in patients with suspected PE. Methods In a randomized open-label multicentre trial spanning June 18, 2021, through Feb 1, 2023, adult patients with suspected PE and 1) a Wells score of 0–6 and elevated age-adjusted D-dimer or 2) Wells score >6 were randomly assigned 1:1 to direct diagnostic imaging (controls) or focused lung, cardiac, and deep venous ultrasound by unblinded investigators. Ultrasound could: 1) dismiss PE if no signs of PE and low clinical suspicion or an alternate diagnosis, 2) confirm PE in case of visible venous thrombus, ≥2 subpleural infarctions, McConnell's, or D-sign, or 3) refer to diagnostic imaging if neither category was fulfilled or a patient with confirmed PE by ultrasound required admission. Primary endpoint was proportion of patients referred to diagnostic imaging. Outcome assessors were not blinded to group assignment. All included participants were included in safety analyses. The trial was registered at clinicaltrials.gov (NCT04882579). Findings A total of 150 patients were recruited, of whom 73 were randomized to ultrasound. Among 77 controls referred to diagnostic imaging, 26 patients had PE confirmed. In the ultrasound group, 40 patients were referred to diagnostic imaging of whom 20 had PE, reducing referral for diagnostic imaging by 45.2% (95% CI: 34.3–56.6, p < 0.0001). Three further PEs were diagnosed by presence of a DVT. During 3-month follow-up, the number of patients who did not receive anticoagulation but was diagnosed with PE was two (4%; 95% CI: 1.1–13.5) and none (0%; 95% CI: 0.0–7.0) in the ultrasound and control group, respectively. Interpretation Ultrasound substantially reduced referral to diagnostic imaging in suspected PE. Albeit with an unacceptable failure rate. Funding University of Southern Denmark, Odense University Hospital, Master Carpenter Sophus Jacobsen and wife’s foundation, Engineer K. A. Rhode and wife foundation.

Keywords

Cardiac, D-dimer, D-sign, DVT, Denmark, McConnell, Odense, Odense University Hospital, Southern Denmark, University Hospital, University of Southern Denmark, Wells score, admission, adult patients, adverse events, age-adjusted D-dimer, alternative diagnoses, analysis, anticoagulation, assessors, assignment, background, background prevalence, cases, clinical suspicion, confirm PE, control, control group, controlled trials, deep venous ultrasound, diagnosis, diagnostic imaging, diagnostic work-up, embolization, endpoint, events, failure, failure rate, follow-up, foundations, funded university, funding, group, group assignment, hospital, images, improve patient selection, infarction, interpretation, interpreting ultrasound, investigation, low clinical suspicion, lung, master, multicentre randomized controlled trial, multicentre trial, open-label multicentre trial, outcome assessors, outcomes, participants, patient selection, patients, presence, prevalence of pulmonary embolism, primary endpoint, proportion, proportion of patients, protocol, pulmonary embolism, randomized controlled trials, rate, reduce referrals, reduction, referral, referrals to diagnostic imaging, safety, safety analysis, scores, selection, study, suspected PE, suspicion, thrombus, trials, ultrasound, ultrasound group, ultrasound protocol, unblinded investigators, utilization, utilization of ultrasound, venous thrombi, venous ultrasound, wells

Funders

  • Novo Nordisk (Denmark)

Data Provider: Digital Science